Ben Dijk

BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands.

Van Wijnen Holding NV operates as a financial holding company with activities in the construction and property development industry. The company is headquartered in Baarn, the Netherlands.

Rabo Private Equity (RPE) is the private equity arm of the Rabobank Group and is headquartered in Utrecht. RPE originated in 1972 following the merger of two separate Dutch cooperative banks, the Cooperatieve Centrale Raiffeisen-Boerenleenbank in Utrecht and the Cooperatieve Centrale Boerenleenbank in Eindhoven. The firm was formally established in 1998. RPE is based in Utrecht and operates through two separate entities, Rabo Participaties and Rabo Capital.

Selo Holding BV offers packaging solutions and complete production lines. It designs and implements processing and packaging systems for customers in the food manufacturing, animal feed, pharmaceutical and non-food industries. The company offers food processing, meat machinery, packaging machines, artificial casings, and pet food equipment. It has offices in Aarhus, Antwerp, Argenbühl, Brie-Comte-Robert, Merseyside and Oldenzaal. Selo Holding was founded in 1989 and is headquartered in Oldenzaal, the Netherlands.

NV NOM (NV NOM) is a private equity firm founded in 1974. The firm is headquartered in Groningen, Netherlands.

Biogeneration Management is a venture capital firm, a subsidiary of BioGeneration Holding BV and was founded in 2006. Biogeneration management is headquartered in Naarden.

NoorderHuys Participaties Management BV (NPM) is a private equity investment firm based in Joure, The Netherlands. NPM was established in 2007 by John Ritchi, Johannes Osinga, Jan ten Cate and Alfred Stel. NPM is experienced in MBOs, growth capital and succession issues within family firms. NPM is the management team of the NoorderHuys Participaties fund. The fund's investors consist of former entrepreneurs as well as several corporate entities.

Mellon Medical BV manufactures and develops surgical suturing devices. The firm’s suturing device, the Switch, is designed for surgeons who perform the challenging operations and can easily be rotated in the hand because of its pencil-like shape. The company was founded in April 2013 by Mark Vrancken Peeters and is headquartered in Nijmegen, the Netherlands.

Ventinova Medical BV develops and markets products in the field of anesthesiology. Its products include Ventrain, Cricath, and Ventrain Emergency Kit. The company was founded by Dirk van Asseldonk in 2013 and is headquartered in Eindhoven, Netherlands.

Nordian Capital BV(Nordian Capital), formerly known as Rabo Capital an independent Netherlands based private equity firm which was founded in September 2014 as a spinoff from Rabobank.

OOK Capital Partners BV is an independent private equity firm with its headquarters in Naarden, the Netherlands. It was founded in 2013.

FB Oranjewoud Participaties BV is a private equity firm, a subsidiary of Stichting FB Oranjewoud founded in 2012. The firm is headquartered in Oranjewoud, the Netherlands.

D.M. Equity General Partners BV is an independent private equity firm with its headquarters in Schiphol, the Netherlands. It was founded in 2016.

Gilde Equity Management is a Private Equity firm founded in 1996. The firm is headquartered in Heemstede Estate, Netherlands.

NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands.

Schoenendoos Rotterdam BV is a private equity firm with headquarters in Rotterdam, The Netherlands. It was founded in 2017.

Sirius Medical BV engages in medical industry. The firm focuses on developing medical devices for oncological surgery. The company was founded by Hubert Martens and Bram Schermers and is headquartered in Eindhoven, the Netherlands.

Flowview Diagnostics B.V. is a company based in Heerenveen, the Netherlands. Flowview Diagnostics specializes in developing technology that enables rapid measurement of multiple physical and chemical characteristics of individual cells. The Dutch company's solution involves using an algorithm to analyze raw data from a flow cytometry machine and present the results to technicians in a simplified 2D image, reducing the amount of false negatives. The company's technology is particularly useful for monitoring minimal residual disease (MRD) in leukemia patients, helping to diagnose possible relapses. Flowview Diagnostics B V was founded by Ton van den Hoven, who has been the CEO since incorporation.

NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands.